Catarina Geraldes

2.3k total citations
33 papers, 357 citations indexed

About

Catarina Geraldes is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Catarina Geraldes has authored 33 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 11 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Catarina Geraldes's work include Multiple Myeloma Research and Treatments (17 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). Catarina Geraldes is often cited by papers focused on Multiple Myeloma Research and Treatments (17 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). Catarina Geraldes collaborates with scholars based in Portugal, Spain and United Kingdom. Catarina Geraldes's co-authors include E. Brücher, Jimin Ren, Éva Tóth, A. Dean Sherry, Jurriaan Huskens, M. Margarida C. A. Castro, William P. Cacheris, Ozren Jakšić, Grzegorz Basak and Zdeněk Kořı́stek and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Catarina Geraldes

28 papers receiving 349 citations

Peers

Catarina Geraldes
Ching-Hui Huang Taiwan
Yuki Nishida Japan
Roger H. Pak United States
Rachel Dobson United Kingdom
Eliška Potůčková Czechia
Soumendra Rana India
Pauline Désogère United States
Eman A. Akam United States
Byron A. Boyce United Kingdom
Ching-Hui Huang Taiwan
Catarina Geraldes
Citations per year, relative to Catarina Geraldes Catarina Geraldes (= 1×) peers Ching-Hui Huang

Countries citing papers authored by Catarina Geraldes

Since Specialization
Citations

This map shows the geographic impact of Catarina Geraldes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catarina Geraldes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catarina Geraldes more than expected).

Fields of papers citing papers by Catarina Geraldes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catarina Geraldes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catarina Geraldes. The network helps show where Catarina Geraldes may publish in the future.

Co-authorship network of co-authors of Catarina Geraldes

This figure shows the co-authorship network connecting the top 25 collaborators of Catarina Geraldes. A scholar is included among the top collaborators of Catarina Geraldes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catarina Geraldes. Catarina Geraldes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Geraldes, Catarina, et al.. (2024). Improving Health Outcomes Through Treatment Sequencing Optimization in Multiple Myeloma: A Simulation Model in Transplant‐Ineligible Patients. Cancer Reports. 7(10). e70027–e70027. 1 indexed citations
3.
Geraldes, Catarina, Ana Bela Sarmento‐Ribeiro, Manuel Neves, et al.. (2024). Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma. Frontiers in Oncology. 14. 1282300–1282300. 4 indexed citations
4.
Laranjeira, Paula, Isabel Silva, Sandra Silva, et al.. (2024). CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression. Frontiers in Oncology. 14. 1380648–1380648. 1 indexed citations
5.
Geraldes, Catarina, et al.. (2023). Rare Invasive Fungal Infections in Hematologic Patients: A Large Unicentric Series. Blood. 142(Supplement 1). 5871–5871.
6.
Jorge, Joana, Joana Neves, Raquel Alves, et al.. (2023). Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies. International Journal of Molecular Sciences. 24(11). 9167–9167. 15 indexed citations
7.
8.
Ribeiro, Letícia, et al.. (2022). The Challenging Management of Acute Thrombotic Microangiopathy in Pregnancy. Acta Haematologica. 146(1). 75–78. 1 indexed citations
9.
Costa, Elı́sio, et al.. (2022). Hematological changes in SARS-COV-2 positive patients. Hematology Transfusion and Cell Therapy. 44(2). 218–224. 13 indexed citations
10.
Geraldes, Catarina, et al.. (2022). Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Psoriasis: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2022. 1–6. 2 indexed citations
11.
Neves, Manuel, et al.. (2021). Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness. PharmacoEconomics. 39(5). 579–587. 13 indexed citations
12.
Pereira, M. Graça, Gabriela Ferreira, Sara Monteiro›, et al.. (2020). The mediator role of unmet needs on quality of life in myeloma patients. Quality of Life Research. 29(10). 2641–2650. 10 indexed citations
13.
14.
João, Cristina, José Guilherme de Freitas, Catarina Geraldes, et al.. (2016). Lenalidomide is effective and safe for the treatment of patients with relapsed multiple myeloma and very severe renal impairment. Annals of Hematology. 95(6). 931–936. 5 indexed citations
15.
Weisel, Katja, Chantal Doyen, Meletios Α. Dimopoulos, et al.. (2016). A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation. Leukemia & lymphoma. 58(1). 153–161. 32 indexed citations
16.
Geraldes, Catarina, Ana Cristina Gonçalves, Artur Paiva, et al.. (2016). Aberrant p15, p16, p53, and DAPK Gene Methylation in Myelomagenesis: Clinical and Prognostic Implications. Clinical Lymphoma Myeloma & Leukemia. 16(12). 713–720.e2. 17 indexed citations
17.
Gonçalves, Ana Cristina, Catarina Geraldes, Amélia Pereira, et al.. (2015). Eritropoietina Sérica como Marcador Prognóstico em Síndrome Mielodisplásica. SHILAP Revista de lepidopterología. 28(6). 720–725. 4 indexed citations
18.
Worel, Nina, Jane F. Apperley, Grzegorz Basak, et al.. (2012). European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization. Transfusion. 52(11). 2395–2400. 16 indexed citations
19.
Malard, Florent, Nicolaus Kröger, Ian H Gabriel, et al.. (2011). Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide. Biology of Blood and Marrow Transplantation. 18(2). 314–317. 32 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ching-Hui Huang Breakdown of academic impact, for papers by Yuki Nishida Breakdown of academic impact, for papers by Roger H. Pak Breakdown of academic impact, for papers by Rachel Dobson Breakdown of academic impact, for papers by Eliška Potůčková Breakdown of academic impact, for papers by Soumendra Rana Breakdown of academic impact, for papers by Pauline Désogère Breakdown of academic impact, for papers by Eman A. Akam Breakdown of academic impact, for papers by Byron A. Boyce
Rankless by CCL
2026